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Abstract
Background: Pericytes are integral members of the neurovascular unit. Using mouse models lacking endothelial-
secreted platelet derived growth factor-B (PDGF-B) or platelet derived growth factor receptor beta (PDGFRb)o n
pericytes, it has been demonstrated that PDGF-B/PDGFRb interactions mediate pericyte recruitment to the vessel
wall in the embryonic brain regulating the development of the cerebral microcirculation and the blood-brain
barrier (BBB). Relatively little is known, however, about the roles of PDGF-B/PDGFRb interactions and pericytes in
the adult brain in part due to a lack of adequate and/or properly characterized experimental models. To address
whether genetic disruption of PDGFRb signaling would result in a pericyte-specific insult in adult mice, we studied
the pattern and cellular distribution of PDGFRb expression in the brain in adult control mice and F7 mice that
express two hypomorphic Pdgfrb alleles containing seven point mutations in the cytoplasmic domain of PDGFRb
that impair downstream PDGFRb receptor signaling.
Results: Using dual fluorescent in situ hybridization, immunofluorescent staining for different cell types in the
neurovascular unit, and a fluorescent in situ proximity ligation assay to visualize molecular PDGF-B/PDGFRb
interactions on brain tissue sections, we show for the first time that PDGFRb is exclusively expressed in pericytes,
and not in neurons, astrocytes or endothelial cells, in the adult brain of control 129S1/SvlmJ mice. PDGFRb co-
localized only with well-established pericyte markers such as Chondroitin Sulfate Proteoglycan NG2 and the xLacZ4
transgenic reporter. We next confirm pericyte-specific PDGFRb expression in the brains of F7 mutants and show
that these mice are viable in spite of substantial 40-60% reductions in regional pericyte coverage of brain
capillaries.
Conclusions: Our data show that PDGFRb is exclusively expressed in pericytes in the adult 129S1/Sv1mJ and F7
mouse brain. Moreover, our findings suggest that genetic disruption of PDGFRb signaling results in a pericyte-
specific insult in adult F7 mutants and will not exert a primary effect on neurons because PDGFRb is not expressed
in neurons of the adult 129S1/SvlmJ and F7 mouse brain. Therefore, mouse models with normal and deficient
PDGFRb signaling on a 129S1/SvlmJ background may effectively be used to deduce the specific roles of pericytes
in maintaining the cerebral microcirculation and BBB integrity in the adult and aging brain as well as during
neurodegenerative and brain vascular disorders.
Background
Pericytes are vascular mural cells embedded within the
basement membrane of capillaries originally discovered
by Rouget in 1873 [1]. In the central nervous system
(CNS), pericytes are widelyb e l i e v e dt ob ei n t e g r a l ,
multifunctional members of the neurovascular unit at
the capillary level [2-5]. Pericytes are seen to ensheathe
microvascular endothelial cells forming multiple
synapse-like “peg-socket” contacts with adjacent
endothelial cells in brain capillaries suggesting the possi-
bility of tightly regulated signaling and functional cou-
pling between these two cell-types [4,6,7]. Although it
has been known that brain capillaries have much greater
pericyte coverage than peripheral vascular beds, the
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have largely been neglected until the past two decades
[6,7].
Much of the recently gained insight into pericyte biol-
ogy arose from the analysis of pericyte deficient trans-
genic mice with disrupted platelet derived growth factor
B (PDGF-B)/platelet derived growth factor receptor beta
(PDGFRb) signaling [8-13]. During development of
brain capillaries PDGFRb is exclusively expressed in
perivascular pericytes [10,14]. In the embryonic neural
tube, endothelial-secreted PDGF-B binds to the
PDGFRb receptor located on the pericyte plasma mem-
brane resulting in dimerization of PDGFRb,s u b s e q u e n t
autophosphorylation of cytoplasmic tyrosine residues
and binding of SH2 domain containing proteins which
in turn initiate a multitude of signal transduction path-
ways ultimately stimulating the proliferation, migration,
and recruitment of pericytes to the vascular wall of
newly formed blood vessels [10,14,15]. Complete knock-
out of Pdgfb or Pdgfrb results in a complete lack of peri-
cytes and embryonic lethality [8,9]. Normal PDGF-B/
PDGFRb interactions and corresponding pericyte
recruitment have been demonstrated to play a pivotal
role in the regulation of the cerebral microcirculation,
including regulating angiogenesis, vascular stability, and
integrity of the blood-brain barrier during embryonic
development [2,7,16]. Although it has been speculated
that brain pericytes might fulfill similar roles in the
adult brain, there is limited in vivo experimental evi-
dence to support such claims. Therefore, the functional
roles of brain pericytes in the adult and aging brain are
relatively less well understood in part due to a lack of
adequate and/or properly characterized experimental
models.
To address whether genetic disruption of PDGFRb
signaling would result in a pericyte-specific insult in
adult mice and may therefore be used to study the roles
of brain pericytes in the adult and aging brain, we
sought to characterize the pattern of expression of
PDGFRb in the adult mouse brain in both control mice
and viable F7 mice with two hypomorphic Pdgfrb alleles
on a 129S1/SvlmJ genetic background [12]. The F7 mice
were generated by seven point mutations in which mul-
tiple cytoplasmic tyrosine residues at positions 578, 715,
739, 750, 770 and 1008 were substituted with phenylala-
nine and the tyrosine at position 1020 was replaced with
isoleucine. As a result of these mutations, Src-, Grb2-,
PI3K-, RasGAP-, SHP-2 and PLCg-dependent down-
stream signaling of the PDGFRb receptor is disrupted.
Impaired PDGFRb downstream signaling in turn results
in diminished pericyte recruitment to the vessel wall
leading to a 55-75% reduction in the number of peri-
cytes in the embryonic CNS at day E14.5 as previously
shown [12]. However, the effects of such alterations in
PDGFRb signaling in the adult mouse brain remain
unknown.
Through dual fluorescent in situ hybridization (FISH),
triple immunofluorescent staining for different cell types
in the neurovascular unit, and a fluorescent in situ
proximity ligation assay (PLA) to visualize molecular
PDGF-B/PDGFRb interactions on brain tissue sections,
we show for the first time that PDGFRb is exclusively
expressed in pericytes in several brain regions in the
adult control 129S1/SvlmJ mouse model, and confirm a
similar pattern of pericyte-specific PDGFRb expression
in the adult brain in F7 mutants on the same genetic
background. We demonstrate that F7 mutants are
viable, but exhibit substantial pericyte reductions in dif-
ferent brain regions offering a prospective model system
appropriate for examining the role of pericytes in the
adult and aging brain.
Results
PDGFRb pericyte-specific expression in the adult brain of
129S1/SvlmJ mice and F7 mutants
The adult murine cerebrum is comprised of multiple
distinct brain structures, including the cortex and hippo-
campus, each demonstrating a unique cytoarchitecture.
In order to provide orientation for later fluorescent
images, we first utilized hematoxylin and eosin histologi-
cal staining to provide a low magnification view of an
adult control 129S1/SvlmJ mouse cerebral hemisphere
adjacent to sections subsequently utilized for fluorescent
imaging experiments (Figure 1a, panel i). Further higher
magnification analysis demonstrates the distinct layered
cytoarchitecture and close approximation between
vascular cells, neurons, and glia in the murine parietal
cortex (Figure 1a, panel ii) and CA1 subfield of the hip-
pocampus (Figure 1a, panel iii).
We then determined the expression pattern of Pdgfrb
mRNA in adult control 129S1/SvlmJ 6 month old
mouse cortex and hippocampus. We show that Pdgfrb
mRNA is exclusively expressed in perivascular cells at
the capillary level as demonstrated in layer III of the
parietal cortex and CA1 subfield of the hippocampus
(Figure 1b, left and right panels), by performing dual
fluorescent in situ hybridization combined with
endothelial-specific GLUT1 immunostaining. Pdgfrb
mRNA expression was restricted to perivascular cells
adjacent to GLUT1-positive brain capillaries in frontal
and temporal cortices as well as the striatum in the
adult 129S1/SvlmJ mouse brain (data not shown).
Next, we studied whether PDGFRb is an abundant
marker expressed in brain pericytes at the protein level
t h a tw o u l de n a b l eu st oq u a n t i f yp e r i c y t ec o v e r a g ei n
various brain regions. We show that PDGFRb is highly
expressed in pericytes on lectin-positive brain capillaries
as illustrated in both layer III of the parietal cortex and
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Page 2 of 11Figure 1 PDGFRb expression in perivascular pericytes in the adult brain in control 129S1/SvlmJ mice and F7 mutants with two
hypomorphic PDGFRb alleles.( a) Bright-field imaging analysis of hematoxylin and eosin stained 6 month old 129S1/SvlmJ mouse cerebral
hemisphere i. Low magnification image depicting brain regions used for fluorescent imaging experiments (broken rectangles). Parietal Ctx,
Parietal Cortex; CA1, CA1 hippocampal subfield. ii-iii. Higher magnification image depicting the layered cytoarchitecture of the somatosensory
parietal cortex (ii) and the CA1 hippocampal subfield (iii). Roman numerals represent cortical layers. Pyr., Pyramidale; Rad., Radiatum. (b)
Representative confocal imaging analysis of dual in situ hybridization for Pdgfrb mRNA (green) and endothelial-specific GLUT1 immunodetection
in brain capillaries (red) in layer III of the parietal cortex (left) and the stratum pyramidale of the CA1 hippocampal subfield (right) in 6 month old
control 129S1/SvlmJ mouse. Scale bar 20 μm. (c) Representative three-color confocal imaging analysis of PDGFRb immunodetection (red), NG2
immunodetection of perivascular pericytes (green), and lectin-positive brain capillaries (blue) in layer III of the parietal cortex (left) and stratum
pyramidale of the CA1 hippocampal subfield (right) in a 6 month old 129S1/SvlmJ mouse. Colocalization: yellow. Scale bar 20 μm. (d)
Representative three-color confocal imaging analysis of PDGFRb immunodetection (green), b-gal nuclear immunodetection of pericyte-specific
LacZ transgene (red), and lectin-positive brain capillaries (white) in layer III of the parietal cortex in a 2 month old xLacZ4 transgenic mouse.
Colocalization, arrows: yellow. Scale bar 20 μm. (e) Representative confocal imaging analysis of PDGFRb immunodetection (red) and lectin-
positive brain capillaries (green) in the parietal cortex of a 6 month old 129S1/SvlmJ littermate control (right) and F7 mouse (left). (f) Graph:
PDGFRb-positive pericyte coverage of lectin-positive brain capillary profiles in the cortex, hippocampus, striatum and cerebellum in 6-8 month
old 129S1/SvlmJ controls and F7 mice. Mean ± SEM and n = 6 animals per genotype.
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Page 3 of 11C A 1s u b f i e l do ft h eh i p p o c a m p u s( F i g u r e1 c ,left and
right panels) by performing three-color immunofluores-
cent staining for PDGFRb and the well-established CNS
pericyte marker NG2 [7,17-19] along with endothelial-
specific Lycopersicon Esculentum lectin fluorescent stain-
ing to visualize brain capillaries. To further confirm
pericyte-specific expression of PDGFRb, we utilized the
xLacZ4 transgenic mouse model which specifically
expresses the lacZ nuclear transgenic reporter in com-
mitted, differentiated and non-proliferating pericytes/
vascular smooth muscle cells [20]. Double immunofluor-
escent staining demonstrates that PDGFRb is exclusively
expressed in pericytes with b-galactosidase (b-gal) posi-
tive nuclear staining located on lectin-positive brain
capillaries in both layer III of the parietal cortex (Figure
1d) and CA1 subfield of the hippocampus (data not
shown). PDGFRb expression was also restricted to NG2-
or nuclear b-gal-positive pericytes located on lectin-
positive brain capillaries in frontal and temporal cortices
as well as the striatum in the adult 129S1/SvlmJ mouse
brain (data not shown).
As shown in Figure 1c-e, PDGFRb immunofluorescent
staining provides a quantitative fluorescent signal that
may be used to determine pericyte coverage of micro-
vascular profiles in mouse brain tissue. Quantification of
pericyte coverage in the adult 6-8 month old control
129S1/SvlmJ mouse cortex, hippocampus, striatum and
cerebellum revealed a 70, 73, 66, and 80% PDGFRb-
positive pericyte coverage of lectin-positive microvessels,
respectively (Figure 1f). Similar analysis of 6-8 month
old F7 mutant mice revealed a 34, 30, 38, 48%
PDGFRb-positive pericyte coverage in the cortex, hippo-
campus, striatum and cerebellum, respectively (Figure
1e-f), indicating a substantial pericyte reduction by 52%,
59%, 43%, and 40%, respectively, compared to controls
in different brain regions in this mouse model. The
observed reductions in pericyte coverage in the F7 mice
were subsequently confirmed in the cortex and hippo-
campus using desmin, another well-established pericyte
marker [14,15,21,22]. Quantification of desmin-positive
pericyte coverage in the adult 6-8 month old control
129S1/SvlmJ and F7 mouse cortex and hippocampus
revealed a similar 52% and 59% reduction in pericyte
coverage of lectin-positive microvessels, respectively.
PDGFRb is not expressed in neurons or astrocytes in the
adult brain of 129S1/SvlmJ mice and F7 mutants
We failed to detect any mouse Pdgfrb mRNA by in situ
hybridization or PDGFRb immunostaining by high reso-
lution confocal microscopy in any other cell types in the
adult control 129S1/SvlmJ or F7 mouse brain (Figure 1b-
e; Figure 2). To confirm that there is no PDGFRb expres-
sion in other cell types in the adult 129S1/SvlmJ and F7
mouse brain, we utilized double immunofluorescent
detection coupled to high resolution confocal microscopy
imaging of PDGFRb and either the neurofilament-H
marker of neuronal cell processes (SMI-32) (Figure 2a,
b), the neuronal-specific nuclear antigen A60 (NeuN)
(Figure 2c, d), or the astrocyte-specific glial fibrillary
acidic protein (GFAP) (Figure 2e, f) along with endothe-
lial-specific fluorescent lectin staining. We show no
detectable colocalization of PDGFRb immunofluorescent
signal with any of the above cell-specific markers in cor-
t e x( F i g u r e2 a ,c ,e ) ,h i p p o c a m p u s( F i g u r e2 b ,d ,f ) ,o r
striatum (data not shown) in the adult 129S1/SvlmJ or F7
mouse brain.
In order to investigate whether a similar pericyte-
restricted pattern of PDGFRb expression is also present
in non-telencephalic brain structures, we conducted
double immunofluorescent detection experiments in the
dorsal medulla oblongata including the nucleus tractus
solitarius, a nucleus previously reported to have neuro-
nal PDGFRb expression [23,24]. In contrast to these
published results, there was no detectable colocalization
of PDGFRb immunofluorescent signal with NeuN-posi-
tive neurons (Figure 2g) or GFAP-positive astrocytes
(data not shown).
PDGF-B/PDGFRb interactions occur only on perivascular
pericytes in the adult mouse brain on 129S1/SvlmJ
genetic background
To further confirm that PDGFRb is only expressed on
brain pericytes and that a lack of PDGFRb on other
CNS cell types is not due to insufficient sensitivity of
conventional immunofluorescent staining, we designed a
fluorescent in situ proximity ligation assay (PLA) to
visualize molecular PDGF-B/PDGFRb interactions in the
adult 129S1/SvlmJ mouse brain. PLA is a well-estab-
lished, antibody based technique designed to visualize
endogenous protein-protein interactions with sufficient
amplification to detect single molecular events without
requiring protein modification, e.g., the creation of
fluorescently tagged fusion proteins [25,26]. We show
that PDGF-B/PDGFRb interactions occur only on
PDGFRb-positive pericytes located on lectin-positive
brain capillaries in layer III of the parietal cortex (Figure
3a), CA1 subfield of the hippocampus (Figure 3b), and
striatum (data not shown) in the adult 129S1/SvlmJ
mouse brain.
Discussion
As our results demonstrate, PDGFRb is exclusively
expressed in brain pericytes and not in neurons, astro-
cytes or endothelial cells in adult, viable mouse models
with normal and deficient PDGFRb signaling, such as
the F7 mutants, on a 129S1/SvlmJ genetic background.
Significantly, this pericyte-specific PDGFRb expression
is observed at both the mRNA and protein level in
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Page 4 of 11Figure 2 PDGFRb is not expressed in neurons or astrocytes in the adult 129S1/SvlmJ and F7 mouse brain.( a, b) Representative confocal
imaging analysis of PDGFRb immunodetection of perivascular pericytes (red), SMI-32 immunodetection of neuronal neurites (green), and lectin-
positive brain capillaries (blue) in 6 month old 129S1/SvlmJ control and 6 month old F7 mouse layer II parietal cortex (a) and stratum radiatum
of the CA1 hippocampal subfield (b). Scale bar 20 μm. (c, d) Representative confocal imaging analysis of PDGFRb immunodetection of
perivascular pericytes (red), NeuN-specific immunodetection of neurons (green), and lectin-positive brain capillaries (blue) in 6 month old 129S1/
SvlmJ control and 6 month old F7 mouse layer III parietal cortex (c) and stratum pyramidale of the CA1 hippocampal subfield (d). Scale bar 20
μm. (e, f) Representative confocal imaging analysis of PDGFRb immunodetection of perivascular pericytes (red), GFAP-specific immunodetection
of astrocytes (green), and lectin-positive brain capillaries (blue) in 6 month old 129S1/SvlmJ control and 6 month old F7 mouse layer III parietal
cortex (e) and stratum pyramidale of the CA1 hippocampal subfield (f). Scale bar 20 μm. (g) Representative confocal imaging analysis of PDGFRb
immunodetection of perivascular pericytes (red), NeuN-specific immunodetection of neurons (green), and lectin-positive brain capillaries (blue) in
6 month old 129S1/SvlmJ control and F7 mouse nucleus tractus solitarius in dorsal medulla oblongata. Scale bar 20 μm.
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Page 5 of 11multiple brain regions. Furthermore, PDGFRb expres-
sion is consistently restricted to brain pericytes with use
of multiple fixatives and tissue processing techniques
during immunofluorescent staining (see Methods). Pre-
vious studies utilizing mice on a 129Sv/C57BL6 genetic
background have also found a similar pericyte-restricted
pattern of PDGFRb expression in mouse brain capil-
laries during embryonic development [10,14]. Moreover,
gene expression profiling on acutely isolated neurons
from C57BL6 mice and S100b (S100 calcium-binding
protein B) transgenic mice expressing enhanced green
fluorescent protein on a hybrid C57BL6/DBA back-
ground failed to detect expression of Pdgfrb in neuronal
cell populations [27,28].
Intriguingly, recent in vitro studies utilizing primary
cortical neurons isolated from C57BL6 mice during
postnatal day 1 and 6 day old cultures have claimed
PDGFRb expression in cultured neurons after 6 days
[29] in contrast to the previous report on acutely
isolated non-cultured neurons from C57BL6 mice or
mice on C57BL6/DBA genetic background showing a
lack of Pdgfrb mRNA expression [27,28]. It remains
unclear as to whether this discrepancy is the result of
alterations in gene expression in response to the growth
factors and/or other constituents in the medium during
culturing [29], and may therefore not accurately repre-
sent the transcriptional profile of neuronal cell popula-
tions in vivo, as suggested by other studies [30-32] or
after an acute isolation of neurons [27,28].
Other studies utilizing adult C57BL6 mice have
further claimed that PDGFRb is expressed in mouse
cortical neurons through ex vivo immunofluorescent
staining and low resolution epi-fluorescent imaging
[23,33]. Although these reports demonstrate PDGFRb
labeling consistent with neurons in size, shape and dis-
tribution, no colocalization studies were conducted and
there is no concluding evidence against or in favor of
neuronal PDGFRb expression. In Ishii et al. 2006 [33],
Figure 3 PDGF-B/PDGFRb interactions occur exclusively on perivascular pericytes in the adult 129S1/SvlmJ mouse brain.( a)H i g h
magnification representative confocal imaging analysis of PDGF-B/PDGFRb proximity interaction (green), PDGFRb immunodetection of
perivascular pericytes (red), and lectin-positive brain capillaries (blue) in 6 month old 129S1/SvlmJ control mouse layer III parietal cortex. Side
panels, orthogonal views. Colocalization: yellow. Scale bar 10 μm. (b) High magnification representative confocal imaging analysis of PDGF-B/
PDGFRb proximity interaction (green), PDGFRb immunodetection of perivascular pericytes (red), and lectin-positive brain capillaries (blue) in 6
month old 129S1/SvlmJ control mouse stratum pyramidale of the CA1 hippocampal subfield. Side panels, orthogonal views. Colocalization:
yellow. Scale bar 10 μm.
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Page 6 of 11the authors further claim to have deleted PDGFRb spe-
cifically from neurons utilizing a nestin-Cre transgenic
system and demonstrate no neuronal phenotype but an
exacerbated response to cryogenic injury of nestin-Cre
+PDGFRb
flox/flox transgenic mice. The interpretation of
Ishii et al. experiments [33] is, however, complicated by
recent findings demonstrating that brain pericytes
express nestin [34] and therefore PDGFRb expression in
pericytes can be affected by nestin-Cre genetic manipu-
lation. Since pericyte number and/or coverage have not
been determined in the nestin-Cre
+PDGFRb
flox/flox trans-
genic mouse model [33], it remains uncertain to what
extent the observed susceptibility to cryogenic brain
injury in this mouse model is due to brain pericyte loss
as opposed to primary neuronal insult.
The same group utilizing organotypic brainstem slices
from mice on a C57BL6 background in conjunction
with single cell patch clamp neuronal recordings has
s u g g e s t e dt h a tn e u r o n a lP D G F R b mediates changes in
the excitatory postsynaptic currents following applica-
tion of human recombinant PDGF-BB onto the slices
[23,24]. It is of note that PDGF-BB binds to other trans-
membrane receptors such as platelet derived growth fac-
tor receptor alpha (PDGFRa) which is abundantly
expressed on neurons in the murine CNS [35-39] and
can contribute to the observed changes in postsynaptic
currents. As a result, it remains unclear as to whether
the observed effects are mediated by binding of recom-
binant PDGF-BB to neuronal PDGFRa at the concentra-
tion utilized and/or whether accompanying PDGF-B/
PDGFRb signaling on brain pericytes may indeed influ-
ence neuronal electrophysiological responses further
complicating the interpretation of these experiments
[24]. In support of our argument, using an in situ proxi-
mity ligation assay capable of detecting single molecular
events, we provide evidence demonstrating that detect-
able PDGF-B/PDGRb interactions on tissue sections
occurs exclusively on microvascular pericytes following
exogenous application of equivalent concentrations (150
ng/mL) of recombinant murine PDGF-BB as in a pre-
vious study [24].
The source of the above contradictions between
reports demonstrating a lack of neuronal PDGFRb
expression in vivo in mouse models on a 129S1/SvlmJ
background in the present study and 129SV/C57BL6
background [10,14] and reports suggesting the presence
of neuronal PDGFRb expression in mouse models on a
C57BL6 background, including the nestin-Cre
+PDGFRb
flox/flox transgenic mouse model [23,24,33]
remains unclear at present time. It is possible, however,
that these conflicting results may be due to subtle
genetic differences between mouse strains with different
genetic backgrounds, as reported by others showing sig-
nificant strain-specific responses to injury and strain-
specific gene expression mapping in the adult mouse
brain [40-43]. Intriguingly, previous reports have
demonstrated neuronal PDGFRb expression in the rat
CNS [44], whereas our work in progress in the adult
human CNS and Alzheimer’s disease patients shows a
pericyte-restricted pattern of PDGFRb expression
[Winkler EA, Bell RD, Zlokovic BV, unpublished results]
indicating that species-specific differences in PDGFRb
expression may indeed exist and that the present mouse
models on a 129S1/SvlmJ background could be poten-
tially used as correlates for human studies on brain
pericytes.
Conclusions
Here we have demonstrated that PDGFRb is exclusively
expressed in brain pericytes and may serve as an abun-
dant pericyte-specific marker in the adult 129S1/Sv1mJ
and F7 mouse brain. Moreover, these findings suggest
that genetic disruption of PDGFRb signaling in adult,
viable mice with this genetic background, such as the F7
mice, will result in a pericyte-specific insult and will not
exert a primary effect on neurons because PDGFRb is
not expressed in neurons of the adult 129S1/SvlmJ and
F7 mouse brain. Therefore, mouse models with normal
and deficient PDGFRb signaling on a 129S1/SvlmJ
genetic background may effectively be used to deduce
the specific roles of pericytes in maintaining the cerebral
microcirculation and BBB integrity within the neurovas-
cular unit in the adult and aging brain as well as during
neurodegenerative and vascular brain disorders.
Methods
Animals
Transgenic F7 mutants and their littermate controls on
a 129S1/SvlmJ genetic background were provided by Dr.
Philippe Soriano (Fred Hutchinson Cancer Res. Cntr.,
Seattle, WA). The F7 mutants were generated by point
mutations in which multiple cytoplasmic tyrosine resi-
dues at positions 578, 715, 739 and 750, 770, 1008 were
substituted with phenylalanine and the tyrosine at posi-
tion 1020 was replaced with isoleucine, thereby disrupt-
ing Src-, Grb2-, PI3K-, RasGAP-, SHP-2 and PLCg-
dependent signal transduction, respectively, as pre-
viously described [12]. This results in a substantial peri-
cyte loss in the embryonic CNS, as shown at day E14.5
[12]. xLacZ4 mice were provided by Dr. Michelle Tall-
quist (UT Southwestern, Dallas, TX). Mice were cared
for in accordance to the University of Rochester Medical
Center Vivarium and Division of Laboratory Animal
Medicine guidelines. All procedures were approved by
the Institutional Animal Care and Use Committee at the
University of Rochester using National Institute of
Health guidelines. Mice were anesthetized with a single
intraperitoneal injection of ketamine (100 mg/kg) and
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Page 7 of 11xylazine (10 mg/kg) and then transcardially perfused
with 50 mL PBS containing 5 U/ml heparin. Brain sec-
tions were prepared as described below.
Hematoxylin and Eosin Histologic Staining
This was performed to provide a detailed view of cere-
bral cytoarchitecture and orientation for fluorescent
imaging. Mice were anesthetized, euthanized, and per-
fused as described above (see Animals). Tissue sections
were subsequently fixed overnight in 4% paraformalde-
hyde (PFA.) Staining was conducted utilizing the FD
hematoxylin solution and FD eosin Y solution (FD Neu-
rotechnologies; Catonsville, MD) as described by the
manufacturer.
Digoxigenein (DIG) labeled oligonucleotides
A 129S1/SvlmJ mouse brain cDNA library was created
from freshly dissected mouse cortex. A 555 bp fragment
of Pdgfrb cDNA was selectively amplified using the fol-
lowing PCR primer combination: 5′- ACCTAGTCGAC-
CACCTTTGTTCTG ACCTGCTC-3′ and 5′-
TTCGTGGATCCATGGTGATGCTCTCGCCCT-3′.T o
facilitate directional cloning, primers were designed to
i n c l u d ea5 ′ overhang containing a 5 nucleotide spacer
sequence and either a SalI or BamHI restriction site in
the forward and reverse primer, respectively. The result-
ing Pdgfrb amplicon was subsequently ligated into the
pBLUESCRIPT II SK vector (Stratagene; Cedar Creek,
TX) containing both T3 and T7 RNA polymerase
sequences. The plasmid was sent to ACGT Inc. (Wheel-
ing, IL) for sequencing to verify proper insertion. The
inserted sequence subsequently aligned to Mus Muscu-
lus Pdgfrb mRNA. Both sense and antisense DIG-labeled
riboprobes were synthesized with the DIG RNA labeling
kit (Roche Applied Science; Indianapolis, IN) utilizing
T7 and T3 RNA polymerase, respectively. The DIG-
labeled riboprobes were then purified using G-50 sepha-
dex quick spin columns (Roche Applied Science) and
diluted to 100 ng/μL in THE RNA storage solution
(Ambion; Austin, TX). All riboprobes were aliquoted
and stored at -80°C.
Dual fluorescent in situ hybridization
The brains of 6-8 month old 129S1/SvlmJ control mice
were studied to determine the pattern of Pdgfrb mRNA
expression in the adult brain utilizing dual fluorescent
in situ hybridization and immunofluorescent staining as
previously described [45,4 6 ] .M i c ew e r ea n e s t h e t i z e d
and transcardially perfused as described above (see Ani-
mals). Snap frozen brains were cryosectioned at 20 μm
and stored at -80°C. The following steps were performed
at 25°C unless otherwise indicated. All solutions were
made using nuclease-free water and glassware was pre-
cleaned using RNase Zap reagent (Ambion). In brief,
sections were allowed to dry for 30 minutes and then
immediately fixed with 4% PFA for 20 minutes. Sections
were then incubated with 0.1 M triethanolamine con-
taining 0.25% (v/v) acetic anhydride to minimize non-
specific binding of the riboprobe for 10 minutes and
were treated with 10 μg/mL proteinase K (Ambion)
diluted in PBS for 10 minutes to facilitate tissue pene-
trance. Sections were then incubated in 5× SSC (0.75 M
NaCl, 0.75 M Na-citrate) for 15 min and then prehybri-
dized with prehybridization buffer (5× SSC, 50% forma-
mide, pH to 7.5 with HCl, 100 μg/ml sheared fish sperm
DNA) for 2 hours at 65°C. Sections were placed in a
humidified chamber and incubated with 300 ng/ml
DIG-labeled probe diluted in prehybridization buffer for
12-16 hours at 65°C. Sections were hybridized with
either antisense or sense riboprobe as a negative control.
Following hybridization, slides were washed with 2× SSC
and 0.1× SSC for 1 hour at 70°C. Sections were rinsed
with PBS and incubated in 3% H2O2 for 1 hour to block
endogenous peroxidase activity. Tyramide signal amplifi-
cation (Invitrogen; Carlsbad, CA) was then conducted as
described by the manufacturer. In brief, sections were
rinsed with PBS and incubated in 10% normal swine
serum (Vector Laboratories; Burlingame, CA) for 1
hour. Sections were then incubated with horseradish
peroxidase (HRP)-conjugated sheep anti-DIG Fab frag-
ments (Roche Applied Science) for 1 hour and rinsed
with PBS. Oregon Green 488-conjugated tyramide
diluted in amplification buffer/0.0015% H2O2 was
applied to the sections for 10 minutes. Sections were
rinsed with PBS and diluted Oregon Green 488-conju-
gated tyramide was reapplied for 10 minutes. Sections
were then incubated with Alexa Fluor 488-conjugated
goat anti-fluorescein/Oregon Green IgG (Invitrogen)
overnight at 4°C. To visualize brain endothelial cells,
sections were incubated with mouse anti-mouse glucose
transporter 1 (GLUT1) IgG (Abcam; Cambridge, MA)
overnight at 4°C. To detect GLUT1, sections were incu-
bated with Alexa Fluor 680-conjugated donkey anti-
mouse IgG (Invitrogen) for 1 hour.
Immunodetection of PDGFRb, Desmin, Chondroitin
Sulfate Proteoglycan NG2 and the xLacZ4 transgenic
reporter
The brains of 6-8 month old 129S1/SvlmJ mice were
studied for co-localization of PDGFRb and the well-
established pericyte marker Chondroitin Sulfate Proteo-
glycan NG2 (NG2) [7,17-19]. Mice were anesthetized
and transcardially perfused as described above (see Ani-
mals). Snap frozen brain sections were cyrosectioned at
14 μm and subsequently fixed in acetone for 10 minutes
at -20°C. Sections were incubated in 10% normal swine
serum (Vector Laboratories) for 1 hour at room
temperature. Sections were then incubated with goat
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MN) and rabbit anti-rat NG2 IgG (Millipore; Billerica,
MA) which cross-reacts with mouse NG2 overnight at
4°C. For PDGFRb and NG2 detection sections were
incubated with Alexa Fluor 546-conjugated donkey anti-
goat IgG (Invitrogen) and Alexa Fluor 488-conjugated
donkey anti-rabbit IgG (Invitrogen), respectively, for 1
hour at room temperature. To visualize brain microvas-
cular endothelial cells, sections were incubated with bio-
tin-conjugated Lycopersicon esculentum (tomato) lectin
(Vector Laboratories) for 1 hour at room temperature
followed by incubation with AMCA-conjugated strepta-
vidin (Vector Laboratories) for 30 minutes at 37°C.
To confirm colocalization of PDGFRb with the
xLacZ4 transgenic reporter, a marker of committed and
differentiated, non-proliferating pericytes/vascular
smooth muscle cells [20], snap frozen 2 month old
xLacZ4 transgenic mouse brain sections were cryosec-
tioned at 14 μm and subsequently fixed in a 1:1 solution
of acetone and methanol for 10 minutes at room tem-
perature. Sections were blocked and incubated with goat
anti- mouse PDGFRb IgG (R&D systems) and mouse
anti-b-galactosidase IgG (Cell Signaling; Danvers, MA)
as described above. For PDGFRb and LacZ detection
sections were incubated with Alexa Fluor 488-conju-
gated donkey anti-goat IgG (Invitrogen; Carlsbad, CA)
and Alexa Fluor 546-conjugated donkey anti-mouse IgG
(Invitrogen), respectively, as described above. Brain
microvascular endothelial cells were visualized with
fluorescent lectin staining as described above.
To study PDGFRb-positive or desmin-positive pericyte
coverage, tissue sections were prepared as described
above. Sections were then incubated with goat anti-
mouse PDGFRb IgG (R&D systems) or mouse anti-
human desmin IgG (Dako USA; Carpinteria, CA) which
cross-reacts with mouse desmin overnight at 4°C. For
PDGFRb and desmin detection sections were incubated
with Alexa Fluor 546-conjugated donkey anti-goat IgG
(Invitrogen; Carlsbad, CA) or Alexa Fluor 546-conju-
g a t e dd o n k e ya n t i - m o u s eI g G( I nvitrogen), respectively,
for 1 hour at room temperature. Brain microvascular
endothelial cells were visualized with fluorescent lectin
staining as described above.
Immunodetection of neuronal-specific and astrocyte-
specific markers
The brains of 6-8 month old 129S1/SvlmJ littermate
controls and 6-8 month old F7 mice were studied for
colocalization of PDGFRb with neuronal neurofilament-
H (SMI-32), neuronal nuclear antigen A60 (NeuN), or
astrocyte glial fibrillary acidic protein (GFAP). Mice
were anesthetized as described above and transcardially
perfused with 10 mL PBS containing 5 U/ml heparin
followed by 30 mL 4% PFA. Brains were carefully
removed from the skull and immersion fixed in 4% PFA
overnight at 4°C. Forty μm vibratome-sectioned brain
sections were incubated in target antigen retrieval solu-
tion, pH 9 (Dako USA) for 15 minutes in a 80°C water
bath and then blocked and incubated with the following
primary antibodies as described above: goat anti-mouse
PDGFRb (R&D systems), mouse anti-mouse SMI-32
(Abcam), mouse anti-mouse NeuN (Millipore), and
mouse anti-mouse GFAP (Cell Signaling). PDGFRb was
detected as described above. To detect NeuN, SMI-32,
and GFAP sections were incubated with Alexa Fluor
488-conjugated donkey anti-mouse IgG for 1 hour at
room temperature. Brain microvascular endothelial cells
were visualized with fluorescent lectin staining as
described above.
Quantification of PDGFRb-positive and Desmin-positive
pericyte coverage of lectin-positive brain microvessels
All images were acquired by a blinded investigator using
a custom-built Zeiss LSM 510 meta confocal laser scan-
ning microscope (see below) using a Zeiss LD LCI Plan-
Apochromat 25×/0.8 Imm Korr DIC water immersion
objective. In each mouse, four different 200 μm × 200
μm fields were analyzed per brain region in six nonadja-
cent sections approximately 100 μma p a r t .P D G F R b-
postive or desmin-positive immunofluorescent and lec-
tin-positive fluorescent signals from brain microvessels
<6μm in diameter were individually subjected to
threshold processing and the areas occupied by their
respective signals were quantified by a blinded investiga-
tor using the NIH Image J software Area measurement
tool. The percent of PDGFRb pericyte coverage of lec-
tin-positive microvessels was then deteremined by nor-
malizing the PDGFRb-positive signal to the lectin
positive-brain microvessel signal. We used Graph-Pad
Prism software for statistical calculations. One-way ana-
lysis of variance followed by a Tukey posthoc test were
used to determine statistically significant differences in
PDGFRb-positive pericyte coverage amongst different
brain regions in both 129S1/SvlmJ mice and F7 mice.
Mean values are reported plus or minus the standard
error of the mean (SEM).
Fluorescent in situ PDGF-B/PDGFRb proximity ligation
assay
The brains of 6-8 month old 129S1/SvlmJ mice were
studied to determine the localization of PDGF-B/
PDGFRb interactions in situ.M i c ew e r ea n e s t h e t i z e d
and transcardially perfused as described above (see
Animals). Frozen brain sections were cryosectioned at
14 μm. Sections were rehydrated with PBS and blocked
with 10% normal swine serum (Vector Laboratories) for
1 hour at room temperature. Sections were then incu-
bated with 150 ng/mL mouse recombinant PDGF-BB
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room temperature. Sections were washed with PBS con-
taining 0.05% triton X-100 and subsequently fixed with
4% PFA for 10 minutes at room temperature. Sections
were incubated with goat anti-mouse PDGFRb IgG
(R&D systems) and rabbit anti-human PDGF-B IgG
(Thermo Scientific; Rockford, IL) which cross reacts
with mouse PDGF-B overnight at 4°C. Proximity ligation
was then conducted in situ as described by the manu-
facturer (Olink Bioscience; Uppsala, SE) utilizing the
Duolink II PLA probe anti-goat PLUS, Duolink II PLA
probe anti-rabbit MINUS, and Duolink II detection
reagents orange to visualize PDGF-B/PDGFRb interac-
tions. Following serial SSC washes, sections were rinsed
with PBS were incubated with biotin-conjugated Lyco-
persicon esculentum lectin (Vector Laboratories) over-
night at 4°C. To visualize brain microvascular
endothelial cells and PDGFRb, sections were incubated
with Dylight 649-conjugated streptavidin (Vector
Laboratories) and Alexa Fluor 488-conguated donkey
anti-goat IgG (Invitrogen), respectively, for 1 hour at
room temperature.
Laser scanning confocal microscopy imaging
All images were acquired using a custom-built Zeiss
LSM 510 meta confocal laser scanning microscope with
a Zeiss LD LCI Plan-Apochromat 25×/0.8 Imm Korr
DIC, C-Apochromat 40X or 63X water immersion
objective (Carl Zeiss Microimaging Inc.; Thronwood,
NY). A 488 nm argon laser was used to excite Alexa
Fluor 488 and the emission was collected through a
500-550 band-pass filter. A 543 HeNe laser was used to
excite Alexa Fluor 546 and the emission was collected
through a 560-615 band-pass filter. A 633 HeNe laser
was used to excite Alexa Fluor 680 and Dylight 649 and
the emission was collected through a 650-710 band-pass
filter. An 800 nm mode-locked femtosecond pulsed
DeepSee Ti:sapphire laser (Spectra Physics; Santa Clara,
CA) was used for AMCA excitation and emission was
collected using 405-450 nm band-pass filter.
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